These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver. Demers A; Samami S; Lauzier B; Des Rosiers C; Ngo Sock ET; Ong H; Mayer G Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2517-25. PubMed ID: 26494228 [TBL] [Abstract][Full Text] [Related]
6. PCSK9, a novel immune and ferroptosis related gene in abdominal aortic aneurysm neck. Zhuang J; Zhu H; Cheng Z; Hu X; Yu X; Li J; Liu H; Tang P; Zhang Y; Xiong X; Deng H Sci Rep; 2023 Apr; 13(1):6054. PubMed ID: 37055467 [TBL] [Abstract][Full Text] [Related]
7. The Effect of a High-Fat Diet on the Development of Abdominal Aortic Aneurysm in a Vascular Hypoperfusion-Induced Animal Model. Hashimoto K; Kugo H; Tanaka H; Iwamoto K; Miyamoto C; Urano T; Unno N; Hayamizu K; Zaima N; Moriyama T J Vasc Res; 2018; 55(2):63-74. PubMed ID: 29393228 [TBL] [Abstract][Full Text] [Related]
8. Ectopic Expression of PCSK9 by Smooth Muscle Cells Contributes to Aortic Dissection. Iida Y; Tanaka H; Sano H; Suzuki Y; Shimizu H; Urano T Ann Vasc Surg; 2018 Apr; 48():195-203. PubMed ID: 29197601 [TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report. Lu H; Howatt DA; Balakrishnan A; Graham MJ; Mullick AE; Daugherty A Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1753-7. PubMed ID: 27470509 [TBL] [Abstract][Full Text] [Related]
10. Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36. Fan FS Tumour Biol; 2023; 45(1):73-80. PubMed ID: 37694331 [TBL] [Abstract][Full Text] [Related]
11. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice. Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220 [TBL] [Abstract][Full Text] [Related]
13. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36. Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222 [TBL] [Abstract][Full Text] [Related]
14. Proprotein convertase subtilisin/kexin type 9 as a drug target for abdominal aortic aneurysm. Golledge J; Lu HS; Shah S Curr Opin Lipidol; 2024 Oct; 35(5):241-247. PubMed ID: 39052843 [TBL] [Abstract][Full Text] [Related]
15. The role of tissue remodeling in mechanics and pathogenesis of abdominal aortic aneurysms. Niestrawska JA; Regitnig P; Viertler C; Cohnert TU; Babu AR; Holzapfel GA Acta Biomater; 2019 Apr; 88():149-161. PubMed ID: 30735809 [TBL] [Abstract][Full Text] [Related]
16. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9. Seidah NG; Abifadel M; Prost S; Boileau C; Prat A Pharmacol Rev; 2017 Jan; 69(1):33-52. PubMed ID: 27920219 [TBL] [Abstract][Full Text] [Related]